Dreaded tick-borne encephalitis virus affects different cell types in the brain, study shows

The dreaded tick-borne encephalitis (TBE) virus infects different types of brain cells in different parts of the brain, depending on whether the affected person's immune system is activated or not. This is shown in a new study at Umeå University, Sweden.

"This increased understanding of how the virus behaves in the brain and how it activates the immune system is a crucial step in the development of effective treatments and preventive measures against this difficult disease," says Anna överby, professor at Umeå University and leader of the research group behind the current study.

What the Umeå researchers have mapped is how the TBE virus infects the brain to cause encephalitis. The researchers developed a method to three-dimensionally determine the location of viruses in the brain of mice and determine which specific parts of the brain have been infected with TBE virus. The method is based on information from image analyses that were combined with studies of gene expression in different cell types. The result can be seen as a virus "road map" in the brain.

It turned out that there was a big difference between the spread of the virus in the brains of mice with and without an innate immune response. The virus infected different regions of the brain depending on the innate immune system of the mouse. When the researchers zoomed in on the cells in the infected brain regions, they could see that the immune system not only affected how the virus spread, it also changed which cell types were infected in the affected regions of the brain.

When the researchers zoomed in further, they could see that in cases where the immune system in the brain could not be activated, the brain's immune cells, microglia, were infected. Their task is otherwise to help prevent and clear the infection. In mice that could activate their immune system in the brain, however, it was mainly nerve cells that were infected.

It is already known that the innate immune system plays an important role in preventing the TBE virus from damaging the brain, but it has been unclear where and which cells they infect.

This is an important piece of the puzzle that is now being put in place. The results underline the importance of the immune system for those infected with TBE. We have also opened up new opportunities to study viruses that infect the brain with the new imaging methods we have developed and by combining them with gene expression analysis from individual cells."

Anna överby, Professor at Umeå University

Tick-borne encephalitis virus, TBEV, is not only a major problem in Sweden, especially in tick-dense areas such as the Stockholm archipelago and in the Mälardalen region, but also a big problem in central and eastern Europe. The virus can cause serious brain inflammation with long-term disabilities as a result. There is currently no curative treatment for TBE, but the most important measures are to prevent infection by avoiding tick bites and to get vaccinated.

Source:
Journal reference:

Chotiwan, N., et al. (2023). Type I interferon shapes brain distribution and tropism of tick-borne flavivirus. Nature Communications. doi.org/10.1038/s41467-023-37698-0.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Study defines three subtypes of Chiari type-1 malformation to guide treatment